So proud of the @23andme team for working with FDA to pave the way for making this important risk information more available to a more diverse population. investors.23andme.com/news-releases/…

New FDA clearance will allow us to improve our BRCA1/BRCA2 (Selected Variants) Genetic Health Risk report* for underrepresented communities. We plan to update the report with 41 additional variants later this year. (1/4) blog.23andme.com/articles/brca1…

In honor of #PFAwarenessMonth, learn more about pulmonary fibrosis, a rare disease where the lung tissue becomes damaged and scarred. 23andme.com/rare-disease-r…

23andMe researchers are studying myelodysplastic syndrome, a rare group of cancers where blood cells do not mature or become healthy, to learn more about the genetics of people living with this disease. Learn more here: 23andme.com/rare-disease-r… #BloodCancerAwarenessMonth

What is myelodysplastic syndrome? It’s a group of disorders caused by blood cells that are poorly formed or don’t work properly. This #MPNAwarenessDay, learn more about the rare disease and our research study. 23andme.com/rare-disease-r…

Dermatomyositis is a rare disease. 23andMe researchers aim to learn more about the genetics of people living with dermatomyositis in the hope that it could ultimately lead to better treatments. Learn more. #MyositisAwarenessDay 23andme.com/rare-disease-r…

What is myelodysplastic syndrome? It’s a group of disorders caused by blood cells that are poorly formed or don't work properly. This #MDSWorldAwarenessDay, learn more about the rare disease and our research study. 23andme.com/rare-disease-r…

In honor of #PSCAwarenessDay, learn more about primary sclerosing cholangitis, a rare disease where the bile ducts inside and outside the liver become inflamed and scarred, and eventually narrowed or blocked. 23andme.com/rare-disease-r…

We're heading to San Diego for the American Association for Cancer Research Annual Meeting to connect and share updates from the 23andMe Therapeutics team. Hope to see you there! More details: 23and.me/4aksIDV #AACR24

We're looking for a Sr. Bioinformatics Scientist to join our Research team! More details here: 23and.me/4aqlFJP

Today at #AACR24, our own Kim Gerrick is presenting at 3:20PM PST in Room 30, hope to see you there!

UPDATE: 23andMe to present preliminary efficacy & biomarker data for 23ME-00610 at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting. More info here: 23and.me/ASCO24 #ASCO2024 #CancerResearch

Study in Nature Medicine shows having 2 copies of APOE4 may cause Alzheimer's, not just increase risk. This shows the value of genetic testing. Early diagnosis = early treatment. Knowledge is power! Read more: 23and.me/3UUNy7q #AlzheimersResearch #GeneticTesting #23andMe

In the latest edition of "Huh, I didn't expect that to work", our latest paper shows that LLMs can outperform existing methods for identifying causal genes in genome-wide association studies. 🧵 medrxiv.org/content/10.110…

Today we’re announcing a new study to advance research on lung cancer. While lung cancer research and targeted therapies have provided hope and progress for many, this study aims to learn more about the genetics behind the disease and its causes. More: 23and.me/3YjhWdH

In a preprint from the 23andMe Research & Therapeutics team, we used Mendelian randomization to explore the genetically-predicted causal effects of Lp(a) on a range (n=489) of human traits and diseases. medrxiv.org/content/10.110…

We're looking for a scientific lead for our long standing (15 years!) Parkinson's disease research program. The program includes over 35k genotyped, consented individuals with PD. If you have a passion for PD and people living with PD, check it out: 23andme.com/careers/jobs/7…

Excited about our latest paper in Blood Advances. Blog post here: blog.23andme.com/articles/new-g…

A blog post on how our data can provide an edge for drug development blog.23andme.com/articles/a-new…